Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (101-110 of 219) with videos related to

Pageof 22
Sort By:
Journal of Virology|March 4, 2011
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cellsJeffrey A Anderson, Nancie M Archin, William Ince, et al.
Journal of Virology|June 5, 2009
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouseShailesh K Choudhary, Naser L Rezk, William L Ince, et al.
AIDS (London, England)|April 15, 2020
Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcingSuzanne Day, Allison Mathews, Meredith Blumberg, et al.
Antiviral Therapy|August 24, 2012
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapyLu Zheng, Ronald J Bosch, Ellen S Chan, et al.
The Journal of Clinical Investigation|February 23, 2011
Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotypeMeagan O'Brien, Olivier Manches, Rachel Lubong Sabado, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNADavid M Margolis, Stephen Kewn, Jason J Coull, et al.
Ebiomedicine|August 15, 2017
Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T CellsJulia A Sung, Katherine Sholtis, Jennifer Kirchherr, et al.
Journal of Virology|March 25, 2021
Defining stable reference genes in HIV latency reversal experimentsCristina Ceriani, Gabrielle S Streeter, Kena J Lemu, et al.
Frontiers in Immunology|August 28, 2020
Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth AssayErin L Stuelke, Katherine S James, Jennifer L Kirchherr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2011
Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patientsBrian D Hodgson, David M Margolis, Donna E Salzman, et al.
Pageof 22

Showing results (101-110 of 219) with videos related to

Sort By:
Pageof 22
Journal of Virology|March 4, 2011
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cellsJeffrey A Anderson, Nancie M Archin, William Ince, et al.
Journal of Virology|June 5, 2009
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouseShailesh K Choudhary, Naser L Rezk, William L Ince, et al.
AIDS (London, England)|April 15, 2020
Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcingSuzanne Day, Allison Mathews, Meredith Blumberg, et al.
Antiviral Therapy|August 24, 2012
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapyLu Zheng, Ronald J Bosch, Ellen S Chan, et al.
The Journal of Clinical Investigation|February 23, 2011
Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotypeMeagan O'Brien, Olivier Manches, Rachel Lubong Sabado, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNADavid M Margolis, Stephen Kewn, Jason J Coull, et al.
Ebiomedicine|August 15, 2017
Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T CellsJulia A Sung, Katherine Sholtis, Jennifer Kirchherr, et al.
Journal of Virology|March 25, 2021
Defining stable reference genes in HIV latency reversal experimentsCristina Ceriani, Gabrielle S Streeter, Kena J Lemu, et al.
Frontiers in Immunology|August 28, 2020
Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth AssayErin L Stuelke, Katherine S James, Jennifer L Kirchherr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2011
Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patientsBrian D Hodgson, David M Margolis, Donna E Salzman, et al.
Pageof 22